You are here
- Home
- Therapy Areas
- Oncology/Infection
A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD3514 in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Disease
- prostate cancer
- Generic Name
- AZD3514
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Aug 23, 2010
- Study Name
- D3760C00001
- Study Id
- D3760C00001
- ClinicalTrials.gov ID
- NCT01162395
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
